A Review Of cGMP in pharma
(d) Any person revealed at any time (either by clinical examination or supervisory observation) to possess an evident sickness or open lesions which will adversely have an affect on the protection or good quality of drug products shall be excluded from immediate contact with components, drug product containers, closures, in-process materials, and d